Protagenic Therapeutics, Inc.\new (PTIX) — Operating Income

Annual figures by fiscal year, from SEC filings.

2014: -$292.1K2015: -$1.03M2016: -$2.23M2017: -$2.37M2018: -$2.31M2019: -$2.09M2020: -$2.55M2021: -$4.14M2022: -$3.56M2023: -$4.53M2024: -$5.70M-$5.70M
2014Operating Income (USD)2024
Fiscal YearOperating IncomeChange YoY
2024-$5.70M-25.9%
2023-$4.53M-27.2%
2022-$3.56M+14.1%
2021-$4.14M-62.3%
2020-$2.55M-22.3%
2019-$2.09M+9.9%
2018-$2.31M+2.2%
2017-$2.37M-5.9%
2016-$2.23M-117.9%
2015-$1.03M-250.9%
2014-$292.1K